Nate Visit 1: A 63-year-old man with fatigue and reduced libido

Title:

Nate Visit 1: A 63-year-old man with fatigue and reduced libido

Topic: Urology
Relevant Terms: Hypogonadism, Men&rsquo,s Health, Low Testosterone, Metabolic Syndrome, Obesity, Erectile Dysfunction
Primary Audience: Primary care physicians and other healthcare providers interested in improving men's health.
Launch Date: 29-May-13
Credits: 0.75 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: How to Get His Game Back: Managing Hypogonadism in Primary Care

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Summarize the diagnostic criteria for hypogonadism using established guidelines.
  2. Describe three possible conditions that are often comorbid to hypogonadism, and implement ways to overcome them in clinical practice.
  3. Evaluate the various treatment options for a man with hypogonadism, in terms of selection, efficacy, safety and contraindications.

    Faculty

    Chad W.M. Ritenour, MD
    Vice Chair of Education and Faculty Affairs
    Associate Professor
    Director, Men's Health Center
    Department of Urology
    Emory University School of Medicine
    Atlanta, GA
    Matt Rosenberg, MD
    Medical Director
    Mid-Michigan Health Centers
    Jackson, MI
    Ronald S. Swerdloff, MD
    Professor of Medicine
    David Geffen School of Medicine at UCLA
    Chief, Division of Endocrinology, Metabolism & Nutrition
    Harbor-UCLA Medical Center
    Torrance, CA
    PROGRAM OVERVIEW:
    Hypogonadism,a condition in which the sex glands produce little or no hormones, is a very prevalent condition that affects 13.8 million men in the United States. The condition is associated with low levels of serum testosterone producing a variety of signs and symptoms including increased fat mass, decreased lean tissue mass, and reduced sex drive, energy, sense of vitality, well being and mood. 
     
    Diagnosis of hypogonadism requires the presence of low serum testosterone levels and the presence of hypogonadal symptoms. Unfortunately, in many cases, hypogonadism often goes unrecognized and under-diagnosed in clinical practice. There are several reasons for these gaps, including a lack of awareness among physicians, perceived difficulty in making an accurate diagnosis, and time constraints of everyday practice. Despite its high prevalence and association with serious comorbid conditions, hypogonadism is persistently undertreated as well. A large number of men remain untreated because of physicians' concern that testosterone therapy may increase the risk of prostate cancer and cardiovascular (CV) diseaseeven though numerous recent scientific studies have shown this is not true. In fact, the opposite may be true as low testosterone levels seem to predispose men to prostate cancer, diabetes and increased mortality and morbidity from CV disease.
     
    At this time, there is a high prevalence of hypogonadism in the older adult male population, and the percentage of older men in the population is projected to rise in the future. As hypogonadism increases with age and is significantly associated with various comorbidities such as obesity, diabetes, hypertension, osteoporosis and metabolic syndrome, physicians are increasingly likely to be faced with hypogonadism on a more and more regular basis. Given the challenges in recognition, diagnosis, and treatment of men with low testosterone along with the growing population of older men in this country, it is essential that clinicians are kept up to date on guidelines, recognition strategies, and treatment modalities for the effective management of hypogonadism.
     
    Faculty
    Activity Leader:
     
    Chad W.M. Ritenour, MD
    Vice Chair of Education and Faculty Affairs
    Associate Professor
    Director, Men's Health Center
    Department of Urology
    Emory University School of Medicine
    Atlanta, GA
     
    Consulting Faculty:
     
    Matt Rosenberg, MD
    Medical Director
    Mid-Michigan Health Centers
    Jackson, MI
     
    Ronald S. Swerdloff, MD
    Professor of Medicine
    David Geffen School of Medicine at UCLA
    Chief, Division of Endocrinology, Metabolism & Nutrition
    Harbor-UCLA Medical Center
    Torrance, CA
     
     
    CME Advisory Committee
     
    Course Director/Course Reviewer
     
    Gailen D. Marshall, Jr., MD, PhD
    Professor of Medicine and Pediatrics
    Vice Chair for Research
    Director, Division of Clinical Immunology and Allergy
    University of Mississippi Medical Center
    Jackson, MS
     
     
    Planning Committee
     
    Joshua Kilbridge
    President
    Kilbridge Associates
    Healthcare Communications
     
    Kelly Kraines
    Director of CME/CE
    Med Learning Group
     
    Christopher Cahill
    Associate Director, Planning and Projects
    Med Learning Group
     
     
    DISCLOSURE POLICY STATEMENT:
    In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
     
    DISCLOSURE OF CONFLICTS OF INTEREST:
     
    Faculty
    Chad Ritenour, MD
    Disclosure: Dr. Ritenour receives funds for expert witness consulting for Abbott Laboratories, Inc.
     
    Matt Rosenberg, MD
    Disclosure: Dr. Rosenberg receives consulting fees from Astellas Pharma US, Inc., Ferring Pharmaceuticals, Horizon Pharma, Eli Lilly & Company, and Pfizer Inc.  He is also on the Speakers' Bureaus for Astellas Pharma US, Inc., Forest Laboratories, Inc., Horizon Pharma, Ortho-McNeil Pharmaceuticals and Pfizer Inc.
     
    Ronald Swerdloff, MD
    Disclosure: Dr. Swerdloff receives consulting fees from Clarus Therapeutics. He also receives grant funding from Clarus Therapeutics and Novartis Corporation.
     
    Gailen Marshall, Jr., MD, PhD
    Disclosure: Dr. Marshall has no relevant financial relationships to disclose.
     
     
    Planning Committee
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
     
    Joshua Kilbridge of Kilbridge Associates has no relevant financial relationships to disclose.
     
    Kelly Kraines of Med Learning Group has no relevant financial relationships to disclose.
     
    Christopher Cahill, of Med Learning Group has no relevant financial relationships to disclose.
     
     
    ACCREDITATION STATEMENT:
    Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    This CME activity was planned and produced in accordance with the ACCME Essentials.

    For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

    Contact this CME provider for privacy and confidentiality policy statement information at:
    http://www.medlearninggroup.com/?page_id=865
     
    CREDIT DESIGNATION STATEMENT:
    Med Learning Group designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    TO OBTAIN CME CREDITS:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • You must score 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
       
    Disclaimer
    Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
     
    DISCLOSURE OF UNLABLED USE:
    Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
     
    COURSE VIEWING REQUIREMENTS:
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    Release Date: May 30, 2013
    Expiration Date: May 29, 2014
     
    MEDIUM: Internet
     
    ACKNOWLEDGEMENT:
    This activity is sponsored by Med Learning group.


    This activity is supported by an educational grants from AbbVie, Inc. & Lilly USA, LLC.
     


     

    If you have any questions regarding this activity, send an email to info@medlearninggroup.com.
     
    This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields.  
     
    Copyright © 2013 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.